Norepinephrine Bitartrate in 5% Dextrose - (4 mg/250 mL and 8 mg/250 mL ; Injection)

Generic Name	Norepinephrine Bitartrate in 5% Dextrose	Innovator	Baxter
Dosage	4 mg/250 mL and 8 mg/250 mL ; Injection	Branded US Sales	Less Than $1000 mn
Probable FTF	Less Than 5	Known Para IV Filers	Less Than 5
Other ANDA developers	Less Than 5	Tentative Approvals	None
Final Approvals	Less Than 5	Generic Launches	Less Than 5
Indication	Norepinephrine Bitartrate in Dextrose Injection is a catecholamine indicated for restoration of blood pressure in adult patients with acute hypotensive states.
Complexities	Yes

Executive Summary

Patent Status

Launch Timelines and Competition

Company	FTF Status / 180 days exclusivity	30-Months stay	Current Litigation Status	Current Approval Status	Likelihood of launch
****** ******	*** \ ***	-**-	*** *********	********	*** ****** *******
*********	** \ ***** ***(*)(*)	*** **, ****	*******	********	******** ** *** **, ****

Chronology Of Events

Norepinephrine Bitartrate in 5% Dextrose - (16 mg/250 mL ; Injection)

Generic Name	Norepinephrine Bitartrate in 5% Dextrose	Innovator	Baxter
Dosage	16 mg/250 mL ; Injection	Branded US Sales	Less Than $1000 mn
Probable FTF	Less Than 5	Known Para IV Filers	Less Than 5
Other ANDA developers	Less Than 5	Tentative Approvals	None
Final Approvals	Less Than 5	Generic Launches	Less Than 5
Indication	Norepinephrine Bitartrate in Dextrose Injection is a catecholamine indicated for restoration of blood pressure in adult patients with acute hypotensive states.
Complexities	Yes

Executive Summary

Patent Status

Launch Timelines and Competition

Company	FTF Status / 180 days exclusivity	30-Months stay	Current Litigation Status	Current Approval Status	Likelihood of launch
****** ******	*** \ ***	-**-	*** *********	********	*** ****** *******
*********	** \ ***** ***(*)(*)	*** **, ****	*******	********	******** ** *** **, ****

Chronology Of Events